Acute Bronchitis
Mostrando 13-24 de 87 artigos, teses e dissertações.
-
13. Seasonal pattern of acute bronchitis in general practice in the United Kingdom 1976-83.
Weekly returns from the Royal College of General Practitioners research unit for acute respiratory illnesses in general practice in the United Kingdom show appreciable variation in attack rates for acute bronchitis, from a peak in January to a trough in August. In 1983, for example, it varied from 171.4 per 100 000 to 34.5 per 100 000. This pattern is identi
-
14. Agglutinin response to bacterial infection in acute exacerbations of chronic bronchitis.
Agglutinin titres to Haemophilus influenzae, Streptococcus pneumoniae, Klebsiella pneumoniae, Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, and Proteus vulgaris in the serum of patients with acute exacerbations of chronic bronchitis, patients producing mucoid sputum, and healthy controls were determined. Serological evidence of infection w
-
15. Respiratory viral infection and wheezy bronchitis in childhood.
The role of respiratory viral infection in wheezy bronchitis was studied in 163 children, aged 0-12 years, in a London general practice. Virological investigations were also performed when these same children had acute upper respiratory illness without wheeze. A virus was isolated in 146 (26.4%) of 554 episodes of wheezy bronchitis, rhinoviruses accounting f
-
16. Serum, saliva, and sputum levels of metronidazole in acute exacerbations of chronic bronchitis.
We have evaluated the absorption and the penetration of metronidazole into the bronchial secretions and saliva in acute infective exacerbations of chronic bronchitis. Seventeen patients were given 400 mg orally three times daily for seven days and "steady state" levels were measured in serum, saliva, and sputum on the last day of treatment. Mean levels in th
-
17. Ampicillin and Tetracycline in the Treatment and Prophylaxis of Chronic Bronchitis
Ampicillin and tetracycline, in doses of 2 g a day, were compared in the treatment of acute exacerbations of chronic bronchitis. Seventy-nine patients were followed for 3 to 29 months and were treated for 118 exacerbations. Clinical improvement occurred after 10 days of treatment with either drug in over 80% of the cases. Haemophilus influenzae and Diplococc
-
18. A search for mycoplasma infections in patients with chronic bronchitis
Throat and bronchoscopy specimens for mycoplasma isolation studies were collected from 22 patients with chronic bronchitis and 20 patients without chronic bronchitis. Twenty-six of 50 patients attending a chronic bronchitis clinic had throat, nasal, or sputum specimens collected for attempted mycoplasma isolation, and all of these patients had multiple serum
-
19. A comparison of ampicillin and amoxycillin in acute on chronic bronchitis.
Twenty-five patients with an acute exacerbation of chronic bronchitis completed a double-blind trial of amoxycillin 1.5 g v ampicillin 4 g daily. After treatment for one week there was no difference between the treatments in the rates of achieving mucoid sputum, reduction in sputum volume, improvement in peak expiratory flow rate, or duration of hospital sta
-
20. Acute Tracheo-bronchitis
-
21. Influence of erdosteine, a mucolytic agent, on amoxycillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis.
Twenty four patients with acute infective exacerbations of chronic bronchitis received amoxycillin alone or in combination with erdosteine (a mucolytic agent) for a week in a double blind, placebo controlled study. Clinical assessment scores, body temperature, serum and sputum amoxycillin concentrations, and sputum culture results were recorded in each group
-
22. THE PATHOGENESIS OF BRONCHIAL CATARRH AND OF ACUTE AND CHRONIC BRONCHITIS
-
23. Reducing antibiotic use for acute bronchitis by giving patients written information
-
24. Comparison of ampicillin and amoxycillin in acute or chronic bronchitis.